SEC Form 25-NSE filed by Medtronic plc.

7/2/25 1:17:58 PM ET

$MDT

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Health Care

Get the next $MDT alert in real time by email

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

UNITED STATES

OMB APPROVAL

OMB Number:		3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:		1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-36820

Issuer:	Medtronic plc
Exchange:	NEW YORK STOCK EXCHANGE LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	20 ON HATCH, LOWER HATCH STREET
	Dublin
Telephone number:

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Guarantor of the 0.25% Senior Notes due 2025

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, NEW YORK STOCK EXCHANGE LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2025-07-02	By	Victoria Paper		Manager, Market Watch
Date		Name		Title

¹	Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Get the next $MDT alert in real time by email

Recent Analyst Ratings for

$MDT

Date	Price Target	Rating	Analyst
6/30/2025		Underperform → Peer Perform	Wolfe Research
6/16/2025	$110.00	Outperform	Leerink Partners
3/4/2025	$92.00 → $107.00	Neutral → Buy	Citigroup
10/10/2024	$98.00 → $105.00	Sector Perform → Outperform	RBC Capital Mkts
8/21/2024	$92.00 → $94.00	Perform	Oppenheimer
8/15/2024	$76.00 → $90.00	Sell → Neutral	UBS
8/14/2024	$100.00 → $85.00	Buy → Hold	Stifel
5/30/2024	$83.00	Sell	Goldman

More analyst ratings

SEC Form 25-NSE filed by Medtronic plc.

7/2/25 1:17:58 PM ET

$MDT

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Health Care

Get the next $MDT alert in real time by email

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

UNITED STATES

OMB APPROVAL

OMB Number:		3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:		1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-36820

Issuer:	Medtronic plc
Exchange:	NEW YORK STOCK EXCHANGE LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	20 ON HATCH, LOWER HATCH STREET
	Dublin
Telephone number:

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Guarantor of the 0.25% Senior Notes due 2025

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

2025-07-02	By	Victoria Paper		Manager, Market Watch
Date		Name		Title

¹	Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Get the next $MDT alert in real time by email

Recent Analyst Ratings for

$MDT

Date	Price Target	Rating	Analyst
6/30/2025		Underperform → Peer Perform	Wolfe Research
6/16/2025	$110.00	Outperform	Leerink Partners
3/4/2025	$92.00 → $107.00	Neutral → Buy	Citigroup
10/10/2024	$98.00 → $105.00	Sector Perform → Outperform	RBC Capital Mkts
8/21/2024	$92.00 → $94.00	Perform	Oppenheimer
8/15/2024	$76.00 → $90.00	Sell → Neutral	UBS
8/14/2024	$100.00 → $85.00	Buy → Hold	Stifel
5/30/2024	$83.00	Sell	Goldman

More analyst ratings

SEC Form 25-NSE filed by Medtronic plc.

Crush Q3 2025 with the Best AI Executive Assistant

Recent Analyst Ratings for
$MDT

SEC Form 25-NSE filed by Medtronic plc.

Crush Q3 2025 with the Best AI Executive Assistant

Recent Analyst Ratings for
$MDT

$MDT
Press Releases

Fastest customizable press release news feed in the world

Medtronic secures CE Mark for MiniMed™ 780G System for insulin-requiring people with diabetes including expanded indications in children as young as two, during pregnancy, and for type 2 diabetes

Watts Water Technologies Names Ryan Lada as Chief Financial Officer

Medtronic announces appointment of MiniMed chief financial officer ahead of intended separation into standalone company

$MDT
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Medtronic upgraded by Wolfe Research

Leerink Partners initiated coverage on Medtronic with a new price target

Medtronic upgraded by Citigroup with a new price target

$MDT
SEC Filings